{
    "organizations": [],
    "uuid": "af6f27f988c5fe9d100c44019fe4f250a4a20b2d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-abiomed-announces-european-approva/brief-abiomed-announces-european-approval-for-impella-5-5-idUSFWN1RH05A",
    "ord_in_thread": 0,
    "title": "BRIEF-Abiomed Announces European Approval (CE Marking) For Impella 5.5™",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 4 (Reuters) - Abiomed Inc:\n* ABIOMED ANNOUNCES EUROPEAN APPROVAL (CE MARKING) FOR IMPELLA 5.5™ AND FIRST PATIENT TREATED AT UNIVERSITY HEART CENTER HAMBURG Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)\n ",
    "published": "2018-04-04T20:06:00.000+03:00",
    "crawled": "2018-04-05T17:25:37.012+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "abiomed",
        "inc",
        "abiomed",
        "announces",
        "european",
        "approval",
        "ce",
        "marking",
        "impella",
        "first",
        "patient",
        "treated",
        "university",
        "heart",
        "center",
        "hamburg",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}